Page last updated: 2024-09-05

pyrilen and isoniazid

pyrilen has been researched along with isoniazid in 1 studies

*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]

*Isoniazid: Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. [MeSH]

Compound Research Comparison

Studies
(pyrilen)
Trials
(pyrilen)
Recent Studies (post-2010)
(pyrilen)
Studies
(isoniazid)
Trials
(isoniazid)
Recent Studies (post-2010) (isoniazid)
51021,8159604,493

Protein Interaction Comparison

ProteinTaxonomypyrilen (IC50)isoniazid (IC50)
MyeloperoxidaseHomo sapiens (human)4.85
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv8.29
Putative FAD-containing monooxygenase MymAMycobacterium tuberculosis H37Rv4.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Lostec, Z; Louletzian, O; Mornet, P; Welker, Y1

Other Studies

1 other study(ies) available for pyrilen and isoniazid

ArticleYear
[Tuberculous osteoarthritis revealed by ankle injury].
    Presse medicale (Paris, France : 1983), 1999, Mar-13, Volume: 28, Issue:10

    Topics: Accidental Falls; Aged; Ankle Injuries; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Ganglionic Blockers; Humans; Isoniazid; Osteoarthritis; Pempidine; Rifampin; Time Factors; Tuberculosis, Osteoarticular

1999
chemdatabank.com